Contact us   |  

The Clinical trials acknowledging the ERN-EuroBloodNet that involve ERN Members and Affiliated partners in at least two Member States are listed below.  

Monitoring period Title Members and Affiliated Partners Member State(s) 
2022 Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome (SINTRA-REV) Assistance Publique-Hôpitaux de Paris, Hôpital Saint-LouisUniversitätsklinikum Carl Gustav Carus and Hospital Universitario Virgen del Rocío France, Germany and Spain

Euro Blood Net